These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29251543)

  • 1. The transpulmonary ratio of endothelin 1 is elevated in patients with preserved left ventricular ejection fraction and combined pre- and post-capillary pulmonary hypertension.
    Meoli DF; Su YR; Brittain EL; Robbins IM; Hemnes AR; Monahan K
    Pulm Circ; 2018; 8(1):2045893217745019. PubMed ID: 29251543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker-specific differences between transpulmonary and peripheral arterial-venous blood sampling in patients with pulmonary hypertension.
    Meoli DF; Clark DE; Davogustto G; Su YR; Brittain EL; Hemnes AR; Monahan K
    Biomarkers; 2020 Mar; 25(2):131-136. PubMed ID: 31903794
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic value and diagnostic properties of the diastolic pulmonary pressure gradient in patients with pulmonary hypertension and left heart disease.
    Dragu R; Hardak E; Ohanyan A; Adir Y; Aronson D
    Int J Cardiol; 2019 Sep; 290():138-143. PubMed ID: 31126737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Biological Insights Into Combined Post- and Pre-Capillary Pulmonary Hypertension.
    Assad TR; Hemnes AR; Larkin EK; Glazer AM; Xu M; Wells QS; Farber-Eger EH; Sheng Q; Shyr Y; Harrell FE; Newman JH; Brittain EL
    J Am Coll Cardiol; 2016 Dec; 68(23):2525-2536. PubMed ID: 27931609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary hypertension due to left heart diseases.
    Vachiéry JL; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs JS; Martinez F; Semigran M; Simonneau G; Wells A; Seeger W
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D100-8. PubMed ID: 24355634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes.
    Palazzini M; Dardi F; Manes A; Bacchi Reggiani ML; Gotti E; Rinaldi A; Albini A; Monti E; Galiè N
    Eur J Heart Fail; 2018 Feb; 20(2):248-255. PubMed ID: 28464427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension.
    Ghio S; Crimi G; Temporelli PL; Traversi E; La Rovere MT; Cannito A; Vizza D; Scelsi L; Raineri C; Guazzi M; Oltrona Visconti L
    Eur J Heart Fail; 2018 Apr; 20(4):725-734. PubMed ID: 29148140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of cardiopulmonary exercise testing in patients with combined post- and pre-capillary pulmonary hypertension due to left heart disease.
    Goda A; Yanagisawa Y; Takeuchi S; Takeuchi K; Kikuchi H; Inami T; Kohno T; Satoh T; Soejima K
    PLoS One; 2023; 18(5):e0286057. PubMed ID: 37216326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-depth haemodynamic phenotyping of pulmonary hypertension due to left heart disease.
    Gerges C; Gerges M; Fesler P; Pistritto AM; Konowitz NP; Jakowitsch J; Celermajer DS; Lang IM
    Eur Respir J; 2018 May; 51(5):. PubMed ID: 29599186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined pre- and post-capillary pulmonary hypertension: The clinical implications for patients with heart failure.
    Ibe T; Wada H; Sakakura K; Ugata Y; Maki H; Yamamoto K; Seguchi M; Taniguchi Y; Jinnouchi H; Momomura SI; Fujita H
    PLoS One; 2021; 16(3):e0247987. PubMed ID: 33651852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diastolic Pressure Difference to Classify Pulmonary Hypertension in the Assessment of Heart Transplant Candidates.
    Wright SP; Moayedi Y; Foroutan F; Agarwal S; Paradero G; Alba AC; Baumwol J; Mak S
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive value of minute ventilation versus carbon dioxide production in pulmonary hypertension associated with left heart disease.
    Zhong X; Tang J; Jiang R; Yuan P; Zhao Q; Gong S; Liu J; Wang L
    Ann Transl Med; 2021 Feb; 9(4):351. PubMed ID: 33708978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary Hypertension in Heart Failure. Epidemiology, Right Ventricular Function, and Survival.
    Gerges M; Gerges C; Pistritto AM; Lang MB; Trip P; Jakowitsch J; Binder T; Lang IM
    Am J Respir Crit Care Med; 2015 Nov; 192(10):1234-46. PubMed ID: 26181215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the new definition of pulmonary hypertension according to world symposium of pulmonary hypertension 2018 on diagnosis of post-capillary pulmonary hypertension.
    Pfeuffer-Jovic E; Weiner S; Wilkens H; Schmitt D; Frantz S; Held M
    Int J Cardiol; 2021 Jul; 335():105-110. PubMed ID: 33823213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline diastolic pressure gradient and pressure reduction in chronic heart failure patients implanted with the CardioMEMS™ HF sensor.
    Wolfson AM; Grazette L; Saxon L; Nazeer H; Shavelle DM; Jermyn R
    ESC Heart Fail; 2018 Jun; 5(3):316-321. PubMed ID: 29498245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of severe combined post- and pre-capillary pulmonary hypertension in a patient with idiopathic restrictive cardiomyopathy.
    Ishihara S; Kioka H; Ohtani T; Asano Y; Yamaguchi O; Hikoso S; Toda K; Saito Y; Sawa Y; Yamauchi-Takihara K; Sakata Y
    Pulm Circ; 2018; 8(3):2045894018770131. PubMed ID: 29575985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of Pulmonary Vascular Resistance and Diastolic Pressure Gradient on the New Definition of Combined Post-Capillary Pulmonary Hypertension.
    Sugimoto K; Yoshihisa A; Nakazato K; Yokokawa T; Misaka T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Ishida T; Takeishi Y
    Int Heart J; 2020; 61(2):301-307. PubMed ID: 32224602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component.
    Caravita S; Faini A; Carolino D'Araujo S; Dewachter C; Chomette L; Bondue A; Naeije R; Parati G; Vachiéry JL
    PLoS One; 2018; 13(6):e0199164. PubMed ID: 29920539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Hypertension Due to Left Heart Disease: Diagnosis, Pathophysiology, and Therapy.
    Al-Omary MS; Sugito S; Boyle AJ; Sverdlov AL; Collins NJ
    Hypertension; 2020 Jun; 75(6):1397-1408. PubMed ID: 32336230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic Phenotyping of Pulmonary Hypertension in Left Heart Failure.
    Naeije R; Gerges M; Vachiery JL; Caravita S; Gerges C; Lang IM
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.